¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦2Â÷ ¿©¼º»ý¸íÀÇ°úÇבּ¸¼Ò Çмú´ëȸ : 2023-12-16

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦2Â÷ ¿©¼º»ý¸íÀÇ°úÇבּ¸¼Ò Çмú´ëȸ : 2023-12-16
±³À°ÀÏÀÚ : 2023-12-16
±³À°Àå¼Ò : ¿¬¼¼¾Ïº´¿ø ¼­¾Ï°­´ç

±³À°ÁÖÁ¦ : Á¦2Â÷ ¿©¼º»ý¸íÀÇ°úÇבּ¸¼Ò Çмú´ëȸ

ÁÖÃÖ±â°ü : ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¿©¼º»ý¸íÀÇ°úÇבּ¸¼Ò

´ã´çÀÚ : ¾î°æÁø
¿¬¶ôó : 02-2228-2232

À̸ÞÀÏ : ob@yuhs.ac

±³À°Á¾·ù : ±âŸ

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 12¿ù 16ÀÏ ¼­¾Ï°­´ç 13:00~13:10 Ãà»ç ¹× °³È¸»ç µî ±è»ó¿î(¿©¼º»ý¸íÀÇ°úÇבּ¸¼Ò)

±³À°½Ã°£ 12¿ù 16ÀÏ ¼­¾Ï°­´ç 13:10~13:25 (ÃÊ·Ï)Fine particulate matter (PM2.5) exposure suppresses the decidualization and implantation of Endometrial stromal cell and trophoblast through PROK1/PROK1R regulation Á¤À±Áö(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 12¿ù 16ÀÏ ¼­¾Ï°­´ç 13:25~13:40 (ÃÊ·Ï)The Effect of Microplastics on the Human Pregnancy at the Maternal Fetal Interface ÇãÇý¿ø(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 12¿ù 16ÀÏ ¼­¾Ï°­´ç 13:40~13:55 (ÃÊ·Ï)Non-invasive fetal electroencephalography (EEG) Emily Lee(¿©¼º»ý¸íÀÇ°úÇבּ¸¼Ò)

±³À°½Ã°£ 12¿ù 16ÀÏ ¼­¾Ï°­´ç 13:55~14:20 Fetal US and Artificial Intelligence ±ÇÀÚ¿µ(¿¬¼¼ÀÇ´ë)

Åä·Ð 12¿ù 16ÀÏ ¼­¾Ï°­´ç 14:20~14:30 Discussion (¿¬¼¼ÀÇ´ë)

ÈÞ½Ä 12¿ù 16ÀÏ ¼­¾Ï°­´ç 14:30~14:40 Coffee Break (¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 12¿ù 16ÀÏ ¼­¾Ï°­´ç 14:40~14:50 (ÃÊ·Ï)Extracellular vesicle hsa-miR-200a-3p and hsa-miR-29a-3p derived from in vitro endometriosis model reduce mitochondrial apoptosis by the autocrine effect ¹èÁö¹Î(¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 12¿ù 16ÀÏ ¼­¾Ï°­´ç 14:50~15:00 (ÃÊ·Ï)Particulate Matter Exposures Induce Adverse Effects on Endometrial cells via Aberrant Inflammatory Pathways in vitro and in vivo ½ÅÀ¯¸®(¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 12¿ù 16ÀÏ ¼­¾Ï°­´ç 15:00~15:10 (ÃÊ·Ï)Transcriptomic patterns in early-secretory and mid-secretory endometrium in a natural menstrual cycle immediately before in vitro fertilization and embryo transfer ¹ÚÇý¹Î(¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 12¿ù 16ÀÏ ¼­¾Ï°­´ç 15:10~15:20 (ÃÊ·Ï)Catheter-Directed Sclerotherapy for Endometrioma; studies over the years and future prospectives ÀÌÀç°æ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 12¿ù 16ÀÏ ¼­¾Ï°­´ç 15:20~15:30 (ÃÊ·Ï)Hormone replacement therapy and Breast cancer incidence in Korean women ÃÖÀº¾Æ(¿¬¼¼ÀÇ´ë)

Åä·Ð 12¿ù 16ÀÏ ¼­¾Ï°­´ç 15:30~15:40 Discussion (¿¬¼¼ÀÇ´ë)

ÈÞ½Ä 12¿ù 16ÀÏ ¼­¾Ï°­´ç 15:40~15:50 Coffee Break (¿¬¼¼ÀÇ´ë)

±âŸ 12¿ù 16ÀÏ ¼­¾Ï°­´ç 15:50~16:40 Æ÷½ºÅÍ ¼¼¼Ç (¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 12¿ù 16ÀÏ ¼­¾Ï°­´ç 16:40~16:50 (ÃÊ·Ï)Immune Characteristics of Tumor-infiltrating Lymphocytes in endometrial cancer; molecular classification ±èÁ¤Ã¶(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 12¿ù 16ÀÏ ¼­¾Ï°­´ç 16:50~17:00 (ÃÊ·Ï)Is Presumed Clinical Stage I Endometrial Cancer in PET-CT and MRI Truly Stage I in Surgical Staging? ¼±±âÀº(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 12¿ù 16ÀÏ ¼­¾Ï°­´ç 17:00~17:10 (ÃÊ·Ï)The effectiveness of CA125 and HE4 as clinical prognostic markers in epithelial ovarian cancer patients with BRCA mutation ÀÌ¿µÁÖ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 12¿ù 16ÀÏ ¼­¾Ï°­´ç 17:10~17:20 (ÃÊ·Ï)Clinical features of cancers diagnosed in patients with Lynch syndrome-associated gene germline mutations ÀÌÁöÀº(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 12¿ù 16ÀÏ ¼­¾Ï°­´ç 17:20~17:30 (ÃÊ·Ï)A comparison of clinical outcomes between Manchester Fothergill and vaginal hysterectomy in the treatment of uterine prolapse Á¶Á¤¼ö(¿¬¼¼ÀÇ´ë)

Åä·Ð 12¿ù 16ÀÏ ¼­¾Ï°­´ç 17:30~17:40 Discussion (¿¬¼¼ÀÇ´ë)

±âŸ 12¿ù 16ÀÏ ¼­¾Ï°­´ç 17:40~18:00 ½Ã»ó½Ä ¹× »çÁøÃÔ¿µ, Æóȸ»ç Á¶½ÃÇö(¿¬¼¼ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦2Â÷ ¿©¼º»ý¸íÀÇ°úÇבּ¸¼Ò Çмú´ëȸ : 2023-12-16""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽŰæ°úÇÐȸ ¿µÈ£³²Áöȸ Ãß°èÇмú´ëȸ : 2023-12-16
´ÙÀ½±Û Á¦3ȸ ÀÎÁ¦´ëÇб³ ºÎ»ê¹éº´¿ø ´ç´¢¹ß ½ÉÆ÷Áö¿ò : 2023-12-16
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 41 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 37 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 33 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 36 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 34 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 64 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 20 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 31 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 29 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 31 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 28 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 26 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 27 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 30 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 33 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷